Key takeaways
The UK is explicitly excluded in OpenEvidence’s current Terms of Use.
The restriction covers use from the UK, even if a clinician already has an account.
The terms also address using the service to provide clinical guidance to people in excluded regions.
Compare replacement tools on supported access, source quality, licensing, and your organisation’s approval.
Current availability signals
UK access excluded by the vendor
OpenEvidence
The September 17 terms identify the UK separately from the EU and EEA. Check the current terms before travel or any change of location.
Confirm UK access and contract
Vera Health
Review the vendor’s data processing agreement and ask which account and organisational terms apply to your setting. Availability alone does not establish suitability.
Check your individual or institutional licence
UpToDate
Compare the reference product and any AI features included in the particular subscription available to you.
Confirm the specific UK offering
DynaMed / Dyna AI
EBSCO’s EU product page is not proof of UK entitlement. Ask which features and licence cover UK clinicians.
What the current terms establish
Section 1 of OpenEvidence’s September 17 Terms of Use identifies the UK as an excluded region. Section 3 also restricts using the service to provide medical advice or clinical guidance to people in excluded regions. Check both your working location and the intended use.
- •This is a product access restriction; it is not a claim that all clinical AI is prohibited in the UK.
- •An account created elsewhere does not remove a location-based restriction.
- •The published terms do not provide a UK relaunch date.
What to do if you see “not available in your country”
First check that you are using the official service and review its current geographic terms. For a UK user, repeated login attempts or a VPN do not change the vendor’s stated permission to use the service. Ask the vendor about your situation if an account or travel arrangement is unclear.
Choosing a replacement for a UK practice
Start with the task you need to complete: a cited answer, a longer reference topic, a prescribing lookup, or document drafting. Test a shortlist on the same non-identifying examples and inspect the original sources.
- •Confirm that UK clinicians can register and that the vendor supports your practice or organisation.
- •Ask which product tier includes the features you need, including any AI add-on.
- •Confirm handling, retention, and deletion of prompts and uploaded files before using patient information.
- •Ask your organisation’s clinical and information-governance teams what approval is required.
Availability and privacy are different questions
OpenEvidence’s September privacy policy describes international transfers to the US and other jurisdictions. That disclosure is not a country eligibility list. For UK access, the explicit restriction in the Terms of Use is the relevant source.